Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRCP | P42785 | 1/20 | 0.43 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.40 |
| ▸ | OPRK1 | P41145 | 6/20 | 0.40 |
| ▸ | F2 | P00734 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | EPHA2 | P29317 | 3/20 | 0.39 |
| ▸ | APLNR | P35414 | 2/20 | 0.39 |
| ▸ | ACE | P12821 | 1/20 | 0.39 |
| ▸ | NMUR2 | Q9GZQ4 | 1/20 | 0.38 |
| ▸ | NMUR1 | Q9HB89 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31437182 | 0.94 | F2 (0.41) | PRCPOPRM1OPRK1F2KMT2A | |
| SCHEMBL31437172 | 0.93 | PRCP (0.44) | PRCPOPRM1OPRK1APLNRACE | |
| SCHEMBL31437210 | 0.92 | ACE (0.44) | PRCPOPRM1OPRK1F2EPHA2 | |
| SCHEMBL31467758 | 0.92 | PRCP (0.46) | PRCPOPRM1OPRK1KMT2AEPHA2 | |
| SCHEMBL31467760 | 0.91 | PRCP (0.45) | PRCPOPRM1OPRK1KMT2AEPHA2 | |
| SCHEMBL31467771 | 0.91 | PRCP (0.43) | PRCPOPRM1OPRK1F2EPHA2 | |
| SCHEMBL31437193 | 0.90 | PRCP (0.51) | PRCPKMT2AACE | |
| SCHEMBL31437205 | 0.87 | OPRM1 (0.45) | OPRM1OPRK1APLNR | |
| SCHEMBL31437170 | 0.87 | EPHA2 (0.44) | PRCPOPRM1OPRK1KMT2AEPHA2 | |
| SCHEMBL31437163 | 0.85 | PRCP (0.44) | PRCPKMT2AEPHA2ACENMUR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025037993-A1 | DOSAGE FORM FOR PEPTIDE AGENTS | MAJEWSKI FILIP (PL) | 2025-02-20 | — | — | WO | disclosed |
| WO-2025037992-A1 | NEW PEPTIDES AND USE THEREOF | MAJEWSKI FILIP (PL) | 2025-02-20 | — | — | WO | disclosed |